News Focus
News Focus
icon url

Doc logic

11/05/25 3:51 PM

#796433 RE: learningcurve2020 #796431

learningcurve2020,

No sense running more trials without manufacturing process or treatment regimen nailed down and that includes new agonists/activation and Flaskworks. Those things are lined up or almost lined up now which gives approval new meaning; ). Best wishes.
icon url

skitahoe

11/05/25 3:55 PM

#796436 RE: learningcurve2020 #796431

I believe it's very different to run a trial with an approved product rather than an experimental one. Once approved I believe that NWBO can charge for the product as well as being paid to permit it.

I believe that several trials will be initiated once we have UK approval. Some may be sponsored solely by the company, but I expect more will come from BP's, etc. who want to prove their product enhances the efficacy of the vaccine. I believe the payments from one or more BP's, and perhaps others, may be quite substantial. These companies will get no, or very few shares at low prices, but provisions that permit them to purchase at higher prices may be included.

Gary
Bullish
Bullish